San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Biolinq is raising $10,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jared Tangney played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Biolinq

Biolinq is dedicated to providing innovative technical solutions to unmet clinical needs by delivering quality products backed by solid science and thoughtful design. Biolinq technology utilizes unique data inputs to sense and analyze your glucose levels, delivering the first intelligent CGM. Our first-of-a-kind intelligent platform assesses your glucose levels, trends, and how food or exercise uniquely impact your blood glucose.

To learn more about Biolinq, visit http://www.biolinq.me/

Contact:
Jared Tangney, Chief Executive Officer
510-847-9655
jared@biolinq.me
https://www.linkedin.com/in/jaredtangney/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved